NASDAQ:IMUX

Immunic Stock Predictions

Healthcare > Biotechnology

Buy IMUX

*Your capital is at risk

$14.17

-0.470 (-3.21%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

IMUX Prediction Chart

IMUX Predictions History

Latest community submissions for IMUX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Alan Pro @Alan.115878	Sep 4, 2019	$16.64 -87.39%	$13.20	X	73.94%	0
Alan Pro @Alan.115878	Sep 2, 2019	$17.50 -89.71%	$17.01	X	97.12%	0
JS Pro	Aug 30, 2019	$16.45 -90.33%	$17.01	X	96.71%	0
CoffeeNtrees @CoffeeNtrees.114765	Aug 30, 2019	$15.75 -90.74%	$17.01	V	92.59%	0
Sameer.Royal.Honey.America.107619	Aug 30, 2019	$17.00 -90.01%	$17.01	X	99.94%	10
Alan Pro @Alan.115878	Aug 30, 2019	$16.62 -90.23%	$17.01	X	97.71%	0
Alan Pro @Alan.115878	Aug 29, 2019	$16.47 -89.86%	$16.25	X	98.65%	1
Alan Pro @Alan.115878	Aug 28, 2019	$13.95 -91.37%	$16.17	V	86.27%	0
Alan Pro @Alan.115878	Aug 27, 2019	$14.87 -89.58%	$14.27	X	95.80%	0
Alan Pro @Alan.115878	Aug 26, 2019	$14.21 -90.17%	$14.46	X	98.27%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IMUX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT IMMUNIC INC.

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by